ReviewWorld journal of gastroenterology2016

Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma.

Yukihiro Haruyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.